Delayed Hypersensitivity with Ferric Carboxymaltose
Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and th...
Main Authors: | Surabhi Sridhara, Rajesh Vilakkathala, Ravindra Prabhu, Karan Saraf |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2017-11-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | http://jcdr.net/articles/PDF/10827/25908-CE(RA1)_F(GG)_PF1(PB_AP)_PFA(MJ_SS).pdf |
Similar Items
-
IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency Anaemia
by: Sree Chandana Damineni, et al.
Published: (2016-11-01) -
Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study
by: Ludovica Dottori, et al.
Published: (2023-09-01) -
Acute hypersensitivity reaction following intravenous ferric carboxymaltose injection for iron deficiency anaemia: a case report.
by: Neeraj Kumar, et al.
Published: (2023-03-01) -
Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
by: Adkinson NF, et al.
Published: (2017-09-01) -
Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial
by: María Jesús Laso-Morales, et al.
Published: (2019-01-01)